How Much Semaglutide to Take for Weight Loss

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide dosing for weight loss follows a gradual titration schedule, starting at 0.25 mg weekly and increasing every four weeks until reaching an effective maintenance level. Clinical trials show that most patients achieve meaningful weight reduction between 1.0 mg and 2.4 mg weekly, though individual responses vary significantly based on genetics, metabolism, and lifestyle factors. PlexusDx provides access to compounded semaglutide injections with personalized dosing protocols tailored to your unique physiology.

Understanding Semaglutide Dosing Schedules for Weight Loss

Semaglutide dosing for weight management follows a structured four-week escalation protocol designed to allow your body to adapt gradually while side effects remain manageable. The standard approach begins with a 0.25 mg subcutaneous injection once weekly, then increases by 0.25 mg every four weeks, progressing through 0.5 mg, 0.75 mg, 1.0 mg, 1.5 mg, and potentially reaching 2.0 mg or 2.4 mg as maintenance doses. This methodical increase helps your appetite-suppression system activate without overwhelming your gastrointestinal tract, which commonly causes nausea during rapid dose escalation.

The "dose ramp" phase typically spans 16 to 20 weeks, meaning most patients don't reach their target dose until four to five months into treatment. Research published in obesity literature documents that patients who follow the standard titration schedule report fewer discontinuations due to side effects compared to those attempting higher doses immediately. Your individual semaglutide dose depends on your weight loss goals, tolerance profile, underlying health conditions, and how your body metabolizes GLP-1 receptor agonists—a factor that PlexusDx can assess through genetic testing.

Average Maintenance Doses and Expected Weight Loss Outcomes

Most patients achieve clinically meaningful weight loss at semaglutide doses between 1.0 mg and 2.4 mg weekly, with the 2.4 mg dose representing the maximum approved concentration for weight loss management. Clinical trial data reveals that patients maintaining a 2.4 mg weekly dose lose approximately 16–18% of their body weight over 68 weeks when combined with lifestyle modifications, compared to roughly 3% in placebo groups. However, substantial weight reduction often begins occurring at lower doses—many individuals see 10–15% body weight reduction at 1.0 mg to 1.5 mg doses, meaning you may not require the maximum concentration to achieve your goals.

The relationship between semaglutide dose and weight loss follows a dose-response curve, but results plateau at higher levels for many patients, suggesting that going higher doesn't always mean better outcomes. Individual factors including baseline body mass index, insulin resistance, metabolic rate, and GLP-1 receptor sensitivity influence whether you'll need a higher maintenance dose to see continued results. PlexusDx emphasizes that your dose may need to increase over time as your body adapts, but your monthly cost remains flat regardless of dose level—your investment stays consistent while your medication adjusts to your progress.

Factors That Influence Your Personalized Semaglutide Dose

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Your medical history also shapes semaglutide dosing decisions—patients with type 2 diabetes, severe insulin resistance, or previous weight loss plateaus on other medications may require higher doses or combination approaches to achieve results. Age, kidney function, liver health, and concurrent medications influence both tolerability and efficacy, which is why PlexusDx structures personalized protocols rather than applying one-size-fits-all dosing. Lifestyle factors including protein intake, exercise frequency, sleep quality, and stress management either amplify or diminish semaglutide's weight-loss effects, meaning your optimal dose depends on the full context of your health picture, not medication alone.

Managing Semaglutide Dose Adjustments and Side Effect Control

Side effects like nausea, vomiting, or constipation sometimes prompt dose adjustments—staying at a lower effective dose often produces better long-term adherence than pushing toward maximum concentration with intolerable symptoms. If you experience significant gastrointestinal upset during the titration phase, your provider may recommend extending the interval between dose increases from four weeks to six or eight weeks, allowing your system additional adaptation time. Alternatively, dietary modifications—eating smaller, protein-rich meals and increasing hydration—frequently resolve side effects without requiring dose reductions, making lifestyle support a critical complement to your semaglutide protocol.

Dose adjustments upward should occur gradually, typically increasing by 0.25 mg increments once every four weeks as tolerated, rather than jumping multiple dose levels simultaneously. If you reach a dose level where weight loss plateaus for several months despite good adherence and healthy habits, PlexusDx can explore whether genetic factors suggest trying a dual-compound approach like GLP-Squared Injection (combining semaglutide and tirzepatide) rather than pursuing ever-higher semaglutide doses alone. Your provider continuously monitors your progress through regular check-ins, adjusting your semaglutide dose strategy based on weight trends, side effect reports, and your personal clinical goals.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What semaglutide dose should I start with for weight loss?

The standard starting dose is 0.25 mg administered as a subcutaneous injection once weekly. This low initiation allows your body to adapt to semaglutide while minimizing nausea and other side effects. Your dose increases by 0.25 mg every four weeks as tolerated, advancing toward your individualized target maintenance dose, which PlexusDx personalizes based on your health profile and genetic factors.

How long does it take to reach my target semaglutide dose?

Reaching your target maintenance dose typically requires 16–20 weeks on the standard four-week titration schedule, meaning most patients spend four to five months completing the dose ramp phase. If you experience side effects requiring slower progression, this timeline may extend to 24+ weeks. Once stabilized at your maintenance dose, you'll continue that level as your ongoing treatment, with adjustments made only if your response changes or you experience new side effects.

Does my PlexusDx semaglutide injection cost change if my dose increases?

No. PlexusDx charges a flat monthly rate of $189 (standard tier) for compounded semaglutide injection regardless of your dose level. Whether you're starting at 0.25 mg or maintaining 2.4 mg weekly, your price remains consistent—your dose may go up, but your cost won't.

What happens if semaglutide stops working or plateaus at my current dose?

Weight loss plateaus are common after several months on a stable dose; they reflect your body's adaptation rather than medication failure. Your provider may recommend continuing the same dose while emphasizing lifestyle intensification, extending treatment duration, or—if genetic testing suggests poor GLP-1 receptor responsiveness—exploring PlexusDx's GLP-Squared dual-compound injection combining semaglutide and tirzepatide for synergistic effects.

Can genetic testing help determine my ideal semaglutide dose?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Semaglutide For Weight Loss 2
• Semaglutide Tablets For Weight Loss
• Semaglutide Pills For Weight Loss
• Oral Semaglutide Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.